GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Fisher & Paykel Healthcare Corp Ltd (ASX:FPH) » Definitions » Change In Other Working Capital

Fisher & Paykel Healthcare (ASX:FPH) Change In Other Working Capital : A$0 Mil (TTM As of Sep. 2024)


View and export this data going back to 2001. Start your Free Trial

What is Fisher & Paykel Healthcare Change In Other Working Capital?

Fisher & Paykel Healthcare's Change In Other Working Capital for the quarter that ended in Sep. 2024 was A$0 Mil. It means Fisher & Paykel Healthcare's Other Working Capital stayed the same from Mar. 2024 to Sep. 2024 .

Fisher & Paykel Healthcare's Change In Other Working Capital for the fiscal year that ended in Mar. 2024 was A$0 Mil. It means Fisher & Paykel Healthcare's Other Working Capital stayed the same from Mar. 2023 to Mar. 2024 .

Fisher & Paykel Healthcare Change In Other Working Capital Historical Data

The historical data trend for Fisher & Paykel Healthcare's Change In Other Working Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Fisher & Paykel Healthcare Change In Other Working Capital Chart

Fisher & Paykel Healthcare Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Change In Other Working Capital
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Fisher & Paykel Healthcare Semi-Annual Data
Mar15 Sep15 Mar16 Sep16 Mar17 Sep17 Mar18 Sep18 Mar19 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23 Mar24 Sep24
Change In Other Working Capital Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Fisher & Paykel Healthcare Change In Other Working Capital Calculation

Change In Other Working Capital is any increase or decrease between periods of other working capital that are not otherwise classified.

Change In Other Working Capital for the trailing twelve months (TTM) ended in Sep. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was A$0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Fisher & Paykel Healthcare Change In Other Working Capital Related Terms

Thank you for viewing the detailed overview of Fisher & Paykel Healthcare's Change In Other Working Capital provided by GuruFocus.com. Please click on the following links to see related term pages.

Fisher & Paykel Healthcare Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Fisher & Paykel Healthcare Corp Ltd (ASX:FPH) » Definitions » Change In Other Working Capital
Comparable Companies
ASX:AOK ASX:BRK ASX:CTP ASX:SHE ASX:CUE ASX:PVE ASX:ECH ASX:MAY ASX:JPR ASX:BAS ISRG XPAR:EL BDX TSE:7741 XSWX:ALC RMD TSE:4543 OCSE:COLO B WST COO
Traded in Other Exchanges
FSPKF:USA FPH:New Zealand FPLB:Germany FPLB:Germany
Address
15 Maurice Paykel Place, East Tamaki, Auckland, NTL, NZL, 2013
Website
https://www.fphcare.com
Fisher & Paykel Healthcare is one of the three largest respiratory care device companies globally. It is the market leader in hospital use humidifiers, masks and related consumables and the number three player in the at-home treatment of sleep apnea using respiratory devices. Both the hospital and homecare markets for respiratory devices are growing strongly in the developed markets in which Fisher & Paykel has a presence. The company earns 42% of its revenue in the US, 32% in Europe, 18% in Asia-Pacific and the remaining 8% in emerging markets. Fisher conducts its own R&D and has thousands of patents and pending applications. It manufactures in New Zealand and Mexico and has a multichannel distribution model.